Fig. 1From: Effect of a prebiotic supplement on knee joint function, gut microbiota, and inflammation in adults with co-morbid obesity and knee osteoarthritis: study protocol for a randomized controlled trialSchedule outlining the enrolment, interventions, and assessments for the proposed randomized controlled trial. Following eligibility assessment and informed consent collection (month 0), participants will be randomly allocated to either prebiotic (oligofructose-enriched inulin; 16 g/day) or placebo (maltodextrin; 6.6 g/day). Follow-up assessments will be performed at 3 and 6 months. After the 6 months’ intervention period, participants will stop taking study products and will be assessed again at 9 months to determine the persistence of the effectsBack to article page